Pair Name | Polyphyllin I, Enzalutamide | ||
Phytochemical Name | Polyphyllin I (PubChem CID: 72960700 ) | ||
Anticancer drug Name | Enzalutamide (PubChem CID: 15951529 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Polyphyllin I, Enzalutamide | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Gene Regulation | Down-regulation | Expression | MUC1 | hsa4582 |
Down-regulation | Expression | RELA | hsa5970 | |
In Vitro Model | DU145 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0105 |
PC-3 | Prostate carcinoma | Homo sapiens (Human) | CVCL_0035 | |
In Vivo Model | DU145 prostate cancer cells carrying the luciferase report gene (1×10⁶ cells) in 100 µL PBS were implanted via subcutaneous injection into the flanks of the mice. | |||
Result | Our results indicate that PPI inhibits the growth of CRPC cells by inhibiting p65 protein and concomitantly reducing HOTAIR expression, thereby suppressing MUC1 gene expression. The novel regulatory interaction of p65 and HOTAIR converge in the inhibition of MUC1 expression and overall PPI response. The combination of PPI and enzalutamide exhibits synergy. This study reveals a novel mechanism underlying the synergistic inhibitory effect of PPI and enzalutamide on the growth of CRPC cells. |
No. | Title | Href |
---|---|---|
1 | Crosstalk of NF-κB/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment. Cell Physiol Biochem. 2018;47(2):759-773. doi: 10.1159/000490028. | Click |